Company intelligence / Profile preview
Pascal Biosciences
Vancouver, British Columbia, Canadaca.linkedin.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Pascal's lead programs included:
- PAS‑403 — a small molecule therapeutic advancing toward clinical trials for glioblastoma with demonstrated activity in animal models and blood-brain barrier penetration.
- PAS‑393 — an immuno-stimulatory cannabinoid designed to enhance the efficacy of checkpoint inhibitor therapies; preclinical data showed immune cell recruitment to tumors.
- A B-cell targeted antibody program aimed at acute lymphoblastic leukemia.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small moleculesCannabinoid-based therapeuticsMonoclonal antibodies
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
SōRSE Technology Corporation – collaboration on oral cannabinoid delivery formulation optimized for clinical use with checkpoint inhibitors.Mitacs – partnership supporting cancer research at University of British Columbia.
Beyond the preview
Go deeper on Pascal Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pascal Biosciences.